Purchase Order 19CB6020P0549

This is a delivery order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the provision of reagents with a cost per test agreement, under the Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III). The contract has a firm fixed price and a potential value of $313,442.24. It was awarded on September 5, 2017 and is set to be completed by August 15, 2022. The contract...

This is a delivery order issued by the Department of the Army Medical Command to Biomerieux Inc. for the provision of ID/AST cards and reagents. The contract has a potential value of $114,216.79 and covers the period from October 1, 2018 to September 30, 2019. The contract is a firm fixed price award and was not set aside for a specific business type. Biomerieux Inc. is a for-profit, foreign-owned manufacturer of diagnostic products. The company has an extensive history of providing microbiology...

This is a delivery order awarded by the Department of the Army Medical Command to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic products and solutions. The delivery order, valued at $213,300.68, is for the provision of ID/AST cards and reagents from October 1, 2020 to September 30, 2021. It is not set aside for a specific business type. Biomerieux Inc. is a leading global provider of clinical diagnostic testing equipment, assays, and related consumables. The...

This is a firm-fixed-price purchase order awarded by the Bureau of Medicine and Surgery (part of the U.S. Navy) to Biomerieux Inc. for the procurement of Biomerieux EMAG reagents. The contract has a period of performance through April 8, 2025 and a ceiling value of $28,840.20. The requirement was sole-sourced to Biomerieux as the only known provider of the EMAG reagents needed by the Naval Health Research Center (NHRC) in San Diego. This purchase order is likely part of a larger Indefinite...

This is a $235,020.16 firm fixed price purchase order awarded by the Defense Health Agency to Biomerieux Inc., a foreign-owned, for-profit manufacturer of diagnostic goods. The contract is for pathogenic bacteria cost per reportable, with a completion date of June 30, 2023. The original solicitation requested responses in the prescribed SF1449 format, with pricing on the provided contract line items. Biomerieux Inc. is a leading global provider of in vitro diagnostic solutions, including...

This is a firm-fixed price delivery order awarded by the Department of the Air Force Air Education and Training Command to Biomerieux Inc., a foreign-owned for-profit manufacturer of diagnostic goods. The $103,729.72 contract is for the provision of microbiology reagents and supplies, with a period of performance through September 30, 2022. Biomerieux Inc. is a global leader in in vitro diagnostics, offering solutions for medical and industrial microbiology testing. The company has an...

The Department of the Navy Bureau of Medicine and Surgery awarded Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods, a firm fixed-price delivery order contract valued at $281,620.00 for VITEK 2 REAGENT BOX (AST). This contract is not a set-aside. Biomerieux Inc. is a leader in in vitro diagnostics, providing microbiology testing solutions for medical and industrial applications. The company has previously received federal contracts and task orders from agencies such as the...

This is a $29,347.70 firm-fixed-price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, to Biomerieux Inc. for the supply of Campylobacter detection kits under an existing contract (Contract # 123A9424D0004). The delivery order is part of the third quarter requirements under that contract, which has an ultimate completion date of June 20, 2025. The contract does not have a set-aside designation. Biomerieux Inc., a global leader in...

This is a federal contract awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of reagents, materials, and test supplies. The $15,370.43 firm-fixed-price contract has an ultimate completion date of October 15, 2024. Biomerieux Inc., through its Biomerieux, Inc. division, provides a wide range of clinical diagnostic equipment, reagents, and supplies to various federal agencies, including the Departments of Veterans Affairs,...

Biomerieux Inc. was awarded a firm fixed price purchase order valued at one hundred fifty-five thousand, nine hundred thirteen dollars and twelve cents ($155,913.12) by the Department of Health and Human Services' Food and Drug Administration to provide Salmonella, Listeria and QCV Reagent Test Kits. The test kits will support the FDA Northeast Food and Feed Laboratory's screening of imported and domestic food products for potential pathogens using VIDAS instruments, as initially solicited...